Phenotype and function of nasal dendritic cells.

Mucosal Immunol

1] Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA [2] Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Published: September 2015

Intranasal (i.n.) vaccination generates immunity across local, regional, and distant sites. However, nasal dendritic cells (DCs), pivotal for the induction of i.n. vaccine-induced immune responses, have not been studied in detail. Here, by using a variety of parameters, we define nasal DCs in mice and humans. Distinct subsets of "classical" DCs, dependent on the transcription factor zbtb46 were identified in the murine nose. The murine nasal DCs were Fms-related tyrosine 3 kinase ligand responsive and displayed unique phenotypic and functional characteristics, including the ability to present antigen, induce an allogeneic T-cell response, and migrate in response to lipopolysaccharide or live bacterial pathogens. Importantly, in a cohort of human volunteers, BDCA-1(+) DCs were observed to be the dominant nasal DC population at steady state. During chronic inflammation, the frequency of both BDCA-1(+) and BDCA-3(hi) DCs was reduced in the nasal tissue, associating the loss of these immune sentinels with chronic nasal inflammation. The present study is the first detailed description of the phenotypic, ontogenetic, and functional properties of nasal DCs, and will inform the design of preventative immunization strategies as well as therapeutic modalities against chronic rhinosinusitis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532662PMC
http://dx.doi.org/10.1038/mi.2014.135DOI Listing

Publication Analysis

Top Keywords

nasal dcs
12
nasal
8
nasal dendritic
8
dendritic cells
8
dcs
7
phenotype function
4
function nasal
4
cells intranasal
4
intranasal vaccination
4
vaccination generates
4

Similar Publications

Enterovirus A71 (EV-A71) has caused hand, foot, and mouth disease with an increased prevalence of neurological complications and acute mortality, threatening young children around the globe. By provoking mucosal immunity, intranasal vaccination has been suggested to prevent EV-A71 infection. However, antigens delivered via the nasal route usually fail to induce a protective memory response.

View Article and Find Full Text PDF

Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717.

Front Immunol

January 2025

State Key Laboratory for Animal Disease Control and Prevention & Lanzhou Center for Tuberculosis Research, Institute of Pathogen Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.

Introduction: Vaccines against intracellular pathogens like require the induction of effective cell-mediated immunity. Adjuvants primarily enhance antigen-induced adaptive immunity by promoting the activation of antigen-presenting cells (APCs).This study is to develop an adjuvant targeted to dendritic cells (DCs), one of the main APCs, so as to assist in inducing a long-term cellular immune response to protein antigens.

View Article and Find Full Text PDF
Article Synopsis
  • Lung metastasis is a major cancer-related death cause, but mRNA-based vaccines and intranasal immunization show promise in targeting lung tumors.
  • Researchers developed a novel mRNA nanovaccine that effectively activates immune cells, enhancing their ability to fight cancer.
  • In mouse models, this nanovaccine significantly reduced lung metastasis and improved therapeutic outcomes by boosting the immune response through targeted delivery to the lungs.
View Article and Find Full Text PDF

Objective: Dermoid cyst (DC) is a congenital cyst with the potential to have intracranial extension (ICE). This study aims to evaluate the imaging yield and surgical outcomes of nasal, medial brow, forehead, and scalp DCs.

Design: Retrospective review of craniofacial DCs treated at our institution between 1992 and 2024.

View Article and Find Full Text PDF
Article Synopsis
  • CD169+ macrophages are a newly identified type of immune cell that help in recognizing other cells, important for immune functions, but their role in Allergic Rhinitis (AR) is not fully understood.
  • This research shows a significant increase in CD169+ macrophages in the nasal mucosa of AR patients and develops a mouse model to study their effects on immune cells.
  • Findings suggest that these macrophages boost alanine production and reactive oxygen species (ROS) levels via the Keap1/Nrf2/HO-1 signaling pathway, indicating their crucial involvement in AR.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!